검색으로 돌아가기
기록
TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION
발명심사 중
2조회수
22청구항 · 2 독립항
§ Ⅰ
개요
발명자
Patrick F. Kelly; Alan Collis; Jeff Davis; Duncan Walker; Susan Ashwell; Blythe Thomson; Wei Lu
IPC 분류
A61K 31/4709A61P 35/2C12Q 1/686C12Q 1/6886
CPC 분류
A61K31/4709A61P35/2C12Q1/686C12Q1/6886C12Q2531/113C12Q2561/113C12Q2600/156
Methods of treating patients diagnosed with AML or MDS harboring mutant IDH-1 include detecting an IDH1 mutation and the therapeutic administration of an inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA) or cytarabine.
원문 (중국어)
Methods of treating patients diagnosed with AML or MDS harboring mutant IDH-1 include detecting an IDH1 mutation and the therapeutic administration of an inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA) or cytarabine.